SAS analytics helps Idorsia create new treatments
The pharmaceutical company has built a secure environment for clinical studies and developing new drugs
SAS, one of the world’s largest software manufacturers, has helped the Swiss biopharma company Idorsia to build its new IT infrastructure. Idorsia used SAS Server and SAS Studio to set up a compliant, secure, and easy-to-operate Biometry computing environment.
Idorsia specializes in discovering and developing small molecules and has a broad portfolio of innovative drugs in the pipeline. The company uses SAS to accelerate its research and development activities, with the aim of supplying more patients with new medications faster.
The Idorsia environment uses Amazon Web Services (AWS), which offers advantages with respect to scalability and flexibility. As a result, the company is able to add additional IT resources flexibly, quickly and easily. Being able to deploy servers faster provides a crucial advantage when developing new medicines. Another benefit of this cloud-first strategy is that it ties up much less capital.
“At Idorsia, we have built our entire company IT infrastructure and systems in under one year. To achieve this, it was essential that we opted for cloud solutions to give us speed and agility. Also, we’re planning for the long term, so we need to be flexible and scalable. SAS helped us achieve this and brought new ideas to the table,” said Joel Arida, director of scientific and quality systems at Idorsia. “It was also important to us to go with the vendor that is trusted in equal measure by statisticians, programmers, and government health agencies.”
Another point in favor of SAS was that SAS could be integrated into all processes, procedures, and existing programming right from the start, resulting in extensive synergies.
“Security is really crucial in the pharmaceutical industry. SAS has established itself as a reliable option and the de-facto industry standard,” explained Michaela Mohylova, Account Manager Life Science at SAS DACH. “That’s why we’re excited that Idorsia brought us on board to assist with the important task of keeping their clinical data secure and readily available.”
SAS ist weltweit Marktführer im Bereich Analytics und mit 3,24 Milliarden US-Dollar Umsatz einer der größten Softwarehersteller. Kunden weltweit setzen innovative Software und Services von SAS ein, um Daten in Wissen zu verwandeln und intelligente Geschäftsentscheidungen zu treffen. Seit 1976 verschafft SAS Kunden rund um den Globus THE POWER TO KNOW.
Mit SAS entwickeln Unternehmen Strategien und setzen diese um, messen den eigenen Erfolg, gestalten ihre Kunden- und Lieferantenbeziehungen profitabel, steuern in Echtzeit die gesamte Organisation und erfüllen regulatorische Vorgaben.
Firmensitz der US-amerikanischen Muttergesellschaft ist Cary, North Carolina. SAS Switzerland hat seine Zentrale in Zürich und eine weitere Niederlassung in Genf. Weitere Informationen über SAS.